<DOC>
	<DOCNO>NCT02875691</DOCNO>
	<brief_summary>This randomize double blind clinical trial perform 68 patient ( 32 intervention 36 control group ) diagnose SLE . The patient intervention group give daily dose 1000mg aqueous green tea extract ( 6 gram dry green tea leaf ) form two capsule ( 500 mg ) . Also control group , patient give daily dose 1000mg cellulose form two capsule ( 500 mg ) Variables include SLE disease activity , biomarkers inflammation oxidative stress anthropometric indicator baseline end study . The investigator use SLEDAI ( systemic lupus erythematous disease activity index ) questionnaire evaluate clinical sign disease . The questionnaire fill baseline 3 month .</brief_summary>
	<brief_title>Effect Green Tea Treatment Lupus</brief_title>
	<detailed_description>note</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<criteria>The patient older 15 year , diagnose systemic lupus erythematous ( SLE ) accord ACR ( American College Rheumatology ) criterion . Patients autoimmune disease ( diabetes , ... ) Cardiovascular disease Patients infectious liver disease ; severe infection Pregnancy Breastfeeding Smoking Alcohol consumption Use dietary supplement Changing medication study period</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>disease activity</keyword>
</DOC>